Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Kara Haskell

Physician Assistant, Surgical Bozeman, MT Physician Assistant

NPI 1427414440 CMS profile 10575850

1450 Ellis St, #201, Bozeman, MT 59715

Open in the dashboard

General payments

$1,711

28 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Kara Haskell of Bozeman, MT is reported in the CMS Open Payments database as having received $1,711 across 28 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 82nd percentile of Physician Assistant, Surgical profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $53 3
2024 General $1,260 14
2023 General $48 2
2022 General $171 6
2021 General $179 3

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Kara Haskell
  • Physician Assistant, Surgical median
  • Middle half of Physician Assistant, Surgical
  • National median

In program year 2025, general payments to Kara Haskell were reported at $53. Among 8,152 Physician Assistant, Surgical profiles paid that year, the median was $146 and the middle half received between $51 and $385.

Show as a table
Year Kara Haskell Physician Assistant, Surgical median Middle half National median
2019 $0 — — $163
2020 $0 — — $114
2021 $179 $111 $36–$285 $132
2022 $171 $126 $44–$350 $149
2023 $48 $137 $47–$355 $160
2024 $1,260 $146 $49–$384 $164
2025 $53 $146 $51–$385 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Stryker Corporation $1,388 14 payments
  2. Vericel Corporation $233 9 payments
  3. DePuy Synthes Sales Inc. $40 2 payments
  4. Sioux Surgical Inc $19 1 payment
  5. Zimmer Biomet Holdings, Inc. $16 1 payment
  6. Ferring Pharmaceuticals Inc. $15 1 payment

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $1,058 26 payments
  2. Travel and Lodging $653 2 payments
Products named General payments · program years 2021–2025
  1. PROCINCH $406 1 payment
  2. INSPACE $290 2 payments
  3. MACI $233 9 payments
  4. T2 Nails $121 1 payment
  5. T2 Nails $61 2 payments
  6. HYDROSET $61 2 payments
  7. AXSOS $61 2 payments
  8. MONOVISC $40 2 payments
  9. ORTHOVISC $40 2 payments
  10. NA $36 1 payment
  11. Other $119 5 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 8 drugs

Part D claims

180

Median for Physician Assistant: 241

Drug cost

$1,004

Median for Physician Assistant: $4,110

Branded share of claims

18.9%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Oxycodone Hcl Generic 39 $214
Celecoxib Generic 14 $213
Ondansetron Hcl Generic 42 $157
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 21 $133
Ondansetron Odt Ondansetron Brand 13 $94
Cephalexin Generic 17 $69
Hydromorphone Hcl Generic 11 $68
Meloxicam Generic 23 $57

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 60 billing codes

Paid by Medicare

$51,838

Of which drugs: $13,985

Medicare patients

231

Average age 72

Services billed

2,652

144 women, 87 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 48%
Depression 21%
Diabetes 19%
Ischemic heart disease 19%
Osteoporosis 14%
Chronic kidney disease 13%
Cancer 12%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 131 840 $612

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

28 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant, Surgical in Montana

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record